ketanserin has been researched along with yohimbine in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (22.22) | 18.7374 |
| 1990's | 22 (40.74) | 18.2507 |
| 2000's | 8 (14.81) | 29.6817 |
| 2010's | 12 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amlaiky, N; Boschert, U; Hen, R; Maroteaux, L; Plassat, JL; Saudou, F | 1 |
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Bull, D; den Daas, I; Foord, S; Goodson, S; Kilpatrick, G; Lee, M; Rees, S | 1 |
| Baez, M; Kursar, JD; Nelson, DL; Wainscott, DB | 1 |
| Adham, N; Bard, JA; Branchek, TA; Vaysse, P; Weinshank, RL; Zgombick, J | 1 |
| Audia, JE; Baez, M; Cohen, ML; Kursar, JD; Lucaites, VL; Nelson, DL; Nissen, JS; Schenck, KW; Wainscott, DB | 1 |
| Berardi, F; Caccia, C; Fornaretto, MG; Leopoldo, M; McArthur, RA; Perrone, R; Tortorella, V | 1 |
| Berardi, F; Caccia, C; Colabufo, NA; Fornaretto, MG; Leopoldo, M; McArthur, RA; Perrone, R; Tortorella, V | 1 |
| Gommeren, W; Haegeman, G; Heylen, L; Lesage, AS; Leysen, JE; Luyten, WH; Schotte, A; Van de Weyer, I; Van Gompel, P; Vanhoenacker, P; Wouters, R | 1 |
| Baez, M; Kursar, JD; Lucaites, VL; Nelson, DL; Sasso, DA; Wainscott, DB | 1 |
| Bartoccini, F; Carminati, P; Castorina, M; Di Cesare, MA; Di Serio, S; Gallo, G; Ghirardi, O; Giorgi, F; Giorgi, L; Minetti, P; Piersanti, G; Tarzia, G; Tinti, MO | 1 |
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Colau, D; Dolusić, E; Frédérick, R; Larrieu, P; Masereel, B; Moineaux, L; Pilotte, L; Pochet, L; Stroobant, V; Van den Eynde, B; Wouters, J | 1 |
| Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
| Anzini, M; Brogi, S; Butini, S; Campiani, G; Cappelli, A; Caselli, G; Castriconi, F; Gemma, S; Giordani, A; Giorgi, G; Giuliani, G; Lanza, M; Letari, O; Makovec, F; Manini, M; Mennuni, L; Valenti, S | 1 |
| Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L | 1 |
| Bienkowski, P; Bucki, A; Jaśkowska, J; Kazek, G; Kowalski, P; Kołaczkowski, M; Marcinkowska, M; Mierzejewski, P; Mitka, K; Pawłowski, M; Siwek, A; Wasik, A; Wesołowska, A | 1 |
| Bienkowski, P; Bucki, A; Jastrzębska-Więsek, M; Kazek, G; Kołaczkowski, M; Marcinkowska, M; Mierzejewski, P; Partyka, A; Pawłowski, M; Siwek, A; Śniecikowska, J; Wasik, A; Wesołowska, A | 1 |
| Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E | 1 |
| Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
| Celuch, SM; Enero, MA; Ramirez, AJ | 1 |
| Hansson, E; Nilsson, M; Rönnbäck, L | 1 |
| Bochner, F; Duncan, EM; Lloyd, JV; Rodgers, SE; Vanags, DM | 1 |
| Pinardi, G; Vásquez, JV | 1 |
| Mori, K; Tani, A; Yoshihara, Y | 1 |
| Bellorofonte, C; Dell'Acqua, S; Ruoppolo, M; Tombolini, P; Zaatar, C | 1 |
| Bellorofonte, C; Dell'Acqua, S; Ferri, PM; Ruoppolo, M; Tagliaferri, A; Tombolini, P; Yamak, R; Zaatar, C | 1 |
| Biggio, G; Giorgi, O | 1 |
| Andersson, KE; Forman, A; Funch-Jensen, P; Raundahl, U; Tøttrup, A | 1 |
| Coffman, JD; Cohen, RA | 1 |
| Holmsen, H; Lie, RT; Thorsen, T | 1 |
| Alexander, BS; Broadhurst, AM; Wood, MD | 1 |
| Greiner, HE; Haase, A; Klockow, M; Schmitges, CJ; Seyfried, C | 1 |
| Krootila, K; Palkama, A; Uusitalo, H | 1 |
| Andersson, TL; Larsson, B; Vinge, E | 1 |
| Kawasaki, H; Takasaki, K | 1 |
| Doğan, N; Ilhan, M; Kayaalp, SO; Tuncer, M | 1 |
| Kaumann, AJ | 1 |
| Frenken, M; Kaumann, AJ | 1 |
| Apprill, P; Ashton, J; Buja, LM; Bush, LR; Campbell, WB; Kern, K; Schmitz, J; Tilton, GD; Willerson, JT | 1 |
| Bax, WA; Bos, E; Renzenbrink, GJ; Saxena, PR; Thijssen, EJ; Van Heuven-Nolsen, D | 1 |
| Morris, JL | 1 |
| Bobirnac, I; Schoeffter, P | 1 |
| Bigl, V; Heider, M; Rossner, S; Schliebs, R | 1 |
| Cryan, JF; Harkin, A; Kelly, JP; Leonard, BE; Naughton, M | 1 |
| Matsushima, K; Tozawa, Y | 1 |
| Angers, P; Dalbó, S; Jürgensen, S; Ribeiro-do-Valle, RM; Santos, AR | 1 |
| Centurión, D; Gupta, S; MaassenVanDenBrink, A; Mehotra, S; Sánchez-López, A; Villalón, CM | 1 |
| Honda, M; Ono, H; Ono, K; Takasu, K; Tanabe, M; Tokuda, Y | 1 |
| Gencer, A; Gunduz, O; Ulugol, A | 1 |
| Matsumoto, K; Oka, JI; Sasaki-Hamada, S; Suzuki, A; Ueda, Y | 1 |
1 review(s) available for ketanserin and yohimbine
| Article | Year |
|---|---|
[Endocavernous drug infusions revisited].
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Ketanserin; Male; Papaverine; Penile Erection; Penis; Phentolamine; Vasoactive Intestinal Peptide; Vasodilator Agents; Yohimbine | 1991 |
53 other study(ies) available for ketanserin and yohimbine
| Article | Year |
|---|---|
Mouse 5HT1B serotonin receptor: cloning, functional expression, and localization in motor control centers.
Topics: 3T3 Cells; Adenylyl Cyclases; Amino Acid Sequence; Animals; Base Sequence; Cerebellum; Corpus Striatum; Gene Expression; Genes; GTP-Binding Proteins; Mice; Molecular Sequence Data; Nucleic Acid Hybridization; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Purkinje Cells; Receptors, Serotonin; RNA, Messenger; Serotonin | 1992 |
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Cloning and characterisation of the human 5-HT5A serotonin receptor.
Topics: Amino Acid Sequence; Animals; Base Sequence; Brain Chemistry; Cloning, Molecular; Genome, Human; GTP-Binding Proteins; Humans; Mice; Molecular Sequence Data; Radioligand Assay; Receptors, Serotonin; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Serotonin; Tissue Distribution; Transfection | 1994 |
Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.
Topics: Amino Acid Sequence; Animals; Base Sequence; Brain; Cloning, Molecular; DNA, Complementary; Humans; Molecular Sequence Data; Open Reading Frames; Protein Conformation; Rats; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; RNA, Messenger; Sequence Homology, Amino Acid; Tissue Distribution | 1994 |
Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.
Topics: Adenylyl Cyclases; Base Sequence; Cloning, Molecular; DNA Primers; Humans; Molecular Sequence Data; Receptors, Serotonin; Sequence Alignment; Sequence Homology, Amino Acid; Serotonin Antagonists; Serotonin Receptor Agonists; Signal Transduction | 1993 |
Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
Topics: Animals; Binding Sites; Cell Line; Cloning, Molecular; Gastric Fundus; Inositol 1,4,5-Trisphosphate; Male; Muscle Contraction; Muscle, Smooth; Radioligand Assay; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Temperature | 1993 |
1-aryl-4-[(1-tetralinyl)alkyl]piperazines: alkylamido and alkylamino derivatives. Synthesis, 5-HT1A receptor affinity, and selectivity. 3.
Topics: Animals; Buspirone; Mass Spectrometry; Molecular Structure; Piperazines; Protein Binding; Rats; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Receptor Agonists | 1996 |
Structure-activity relationship studies on the 5-HT(1A) receptor affinity of 1-phenyl-4-[omega-(alpha- or beta-tetralinyl)alkyl]piperazines. 4.
Topics: Magnetic Resonance Spectroscopy; Piperazines; Radioligand Assay; Receptors, Serotonin; Structure-Activity Relationship | 1996 |
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamin
Topics: Animals; Benzopyrans; Cattle; Cloning, Molecular; Glioma; HeLa Cells; Humans; Mice; Migraine Disorders; Propylamines; Protein Binding; Pyrimidines; Radioligand Assay; Receptors, Serotonin; Serotonin Receptor Agonists; Signal Transduction; Tritium; Tumor Cells, Cultured; Vasoconstrictor Agents | 1996 |
[3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.
Topics: Adrenergic alpha-Antagonists; Benzofurans; Binding, Competitive; Cell Line; Cloning, Molecular; Humans; Imidazoles; Radioligand Assay; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Serotonin Antagonists; Transfection; Tritium; Yohimbine | 1998 |
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Cell Line; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Models, Molecular; Motor Activity; Purines; Radioligand Assay; Rats; Rats, Inbred F344; Structure-Activity Relationship; Triazoles | 2005 |
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line; Drug Design; Enzyme Inhibitors; Humans; Immunologic Factors; Indoles; Kinetics; Mice; Neoplasms; Structure-Activity Relationship; Tryptophan Oxygenase | 2011 |
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
Topics: Animals; Area Under Curve; Humans; Intestinal Absorption; Ligands; Male; Metabolic Clearance Rate; Models, Chemical; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Pyrrolidinones; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship | 2013 |
Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Avoidance Learning; Benzoxazoles; Catalepsy; CHO Cells; Cricetulus; Dementia; Dopamine D2 Receptor Antagonists; HEK293 Cells; Humans; Male; Models, Molecular; Motor Activity; Radioligand Assay; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Sulfonamides | 2014 |
Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
Topics: Animals; Benzamides; Dementia; Dose-Response Relationship, Drug; Drug Partial Agonism; Humans; Indoles; Ligands; Male; Models, Molecular; Molecular Structure; Piperazines; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship; Swimming | 2015 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine | 2016 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |
Activation of 5-HT2 receptors inhibits the evoked release of [3H]noradrenaline in the rat spinal cord.
Topics: Amphetamines; Animals; Clonidine; Electric Stimulation; Female; Hallucinogens; In Vitro Techniques; Ketanserin; Norepinephrine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Serotonin Receptor Agonists; Spinal Cord; Yohimbine | 1992 |
Receptor-coupled uptake of valproate in rat astroglial primary cultures.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Astrocytes; Biological Transport; Cells, Cultured; Cerebral Cortex; Clonidine; Drug Interactions; Glutamates; Glutamic Acid; Isoproterenol; Kainic Acid; Ketanserin; Phenylephrine; Prazosin; Quinoxalines; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Serotonin; Valproic Acid; Yohimbine | 1992 |
Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
Topics: Adenosine Diphosphate; Adult; Aspirin; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Female; Humans; In Vitro Techniques; Ketanserin; Male; Platelet Aggregation; Serotonin; Yohimbine | 1992 |
Vasomotor responses in the isolated perfused external and internal carotid vascular beds of the rat.
Topics: Animals; Blood Pressure; Carotid Arteries; Carotid Artery, External; Carotid Artery, Internal; Female; In Vitro Techniques; Ketanserin; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Prazosin; Rats; Serotonin; Sympathetic Nervous System; Yohimbine | 1992 |
Increase in cytoplasmic free Ca2+ elicited by noradrenalin and serotonin in cultured local interneurons of mouse olfactory bulb.
Topics: Animals; Animals, Newborn; Calcium; Cells, Cultured; Cytoplasm; Fura-2; Glutamate Decarboxylase; Immunohistochemistry; Interneurons; Ketanserin; Kinetics; Mice; Mice, Inbred Strains; Microscopy, Fluorescence; Neurofilament Proteins; Norepinephrine; Olfactory Bulb; Prazosin; Serotonin; Yohimbine | 1992 |
[Intracavernous infusion of drugs].
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Ketanserin; Male; Papaverine; Penis; Phentolamine; Vasoactive Intestinal Peptide; Yohimbine | 1992 |
Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Ergolines; Ketanserin; Male; Motor Activity; Prazosin; Quinolines; Quinpirole; Raclopride; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Salicylamides; Yohimbine | 1990 |
Effects of transmural field stimulation in isolated muscle strips from human esophagus.
Topics: Atropine; Carbachol; Electric Stimulation; Esophagus; Humans; In Vitro Techniques; Ketanserin; Muscle Contraction; Muscle, Smooth; Nicotine; Phentolamine; Prazosin; Propranolol; Stomach; Tetrodotoxin; Yohimbine | 1990 |
Alpha-adrenergic and serotonergic mechanisms in the human digit.
Topics: Adult; Blood Pressure; Clonidine; Dose-Response Relationship, Drug; Fingers; Humans; Ketanserin; Phenylephrine; Prazosin; Receptors, Adrenergic, alpha; Receptors, Serotonin; Reflex; Regional Blood Flow; Serotonin; Sympathetic Nervous System; Vascular Resistance; Vasoconstriction; Yohimbine | 1988 |
Induction of platelet aggregation in vitro by microbubbles of nitrogen.
Topics: Adenosine Diphosphate; Aspirin; Drug Synergism; Epinephrine; Gases; Humans; In Vitro Techniques; Indomethacin; Ketanserin; Nitrogen; Platelet Aggregation; Serotonin; Yohimbine | 1989 |
Heterogeneous 3H-rauwolscine binding sites in rat cortex: two alpha 2-adrenoceptor subtypes or an additional non-adrenergic interaction?
Topics: Animals; Binding Sites; Binding, Competitive; Cerebral Cortex; Creatinine; Dioxanes; Drug Combinations; Hippocampus; Ketanserin; Male; Methysergide; Phentolamine; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Serotonin; Spiperone; Spiro Compounds; Yohimbine | 1988 |
Studies on the receptor profile of bisoprolol.
Topics: Adrenergic beta-Antagonists; Animals; Binding, Competitive; Bisoprolol; Cattle; Dihydroalprenolol; Domperidone; Humans; In Vitro Techniques; Ketanserin; Male; Piperidines; Prazosin; Propanolamines; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Histamine; Receptors, Muscarinic; Spiperone; Tetrahydronaphthalenes; Yohimbine | 1986 |
Effect of alpha-adrenergic and serotonergic blockers on the acute irritative response in the rabbit eye.
Topics: Adrenergic alpha-Antagonists; Animals; Aqueous Humor; Blood Pressure; Eye Diseases; Eye Proteins; Female; Formaldehyde; Intraocular Pressure; Ketanserin; Male; Methysergide; Phentolamine; Prazosin; Pupil; Rabbits; Serotonin Antagonists; Yohimbine | 1987 |
Effects of some calcium antagonists on aggregation by adrenalin and serotonin and on alpha-adrenoceptor radioligand binding in human platelets.
Topics: Adrenergic alpha-Antagonists; Calcium Channel Blockers; Diltiazem; Epinephrine; Humans; Ketanserin; Nifedipine; Phentolamine; Platelet Aggregation; Radioligand Assay; Serotonin; Verapamil; Yohimbine | 1988 |
Central alpha-2 adrenoceptor-mediated hypertensive response to clonidine in conscious, normotensive rats.
Topics: Animals; Azepines; Blood Pressure; Brain; Cimetidine; Clonidine; Hydroxydopamines; Injections, Intraventricular; Ketanserin; Male; Methoxamine; Oxidopamine; Piperidines; Prazosin; Procaine; Pyrilamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1986 |
Serotonin-induced contraction of canine saphenous vein: mediation by 5-HT1 receptors.
Topics: Animals; Clonidine; Dogs; Drug Interactions; Emetics; In Vitro Techniques; Ketanserin; Mianserin; Muscle Contraction; Naphthols; Piperidines; Receptors, Serotonin; Saphenous Vein; Serotonin; Yohimbine | 1985 |
Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Arteries; Cattle; Coronary Vessels; Drug Combinations; Ketanserin; Muscle Contraction; Piperidines; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Yohimbine | 1983 |
Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf.
Topics: Animals; Cattle; Coronary Vessels; In Vitro Techniques; Ketanserin; Muscle Contraction; Muscle, Smooth, Vascular; Piperidines; Pulmonary Artery; Receptors, Serotonin; Yohimbine | 1984 |
The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
Topics: Adenosine Diphosphate; Animals; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Dogs; Female; Heart Rate; Hemodynamics; Ketanserin; Male; Piperidines; Platelet Aggregation; Prazosin; Propranolol; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Yohimbine | 1984 |
5-HT receptors mediating contractions of the isolated human coronary artery.
Topics: Adolescent; Adult; Arteries; Blood Platelets; Child; Child, Preschool; Coronary Vessels; Dose-Response Relationship, Drug; Ergotamine; Female; Humans; In Vitro Techniques; Infant; Ketanserin; Male; Metergoline; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Pindolol; Potassium; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Substance P; Sumatriptan; Yohimbine | 1993 |
Blockade of noradrenaline-induced constrictions by yohimbine and prazosin differs between consecutive segments of cutaneous arteries in guinea-pig ears.
Topics: Animals; Arteries; Dihydroergotamine; Ear, External; Female; Guinea Pigs; In Vitro Techniques; Ketanserin; Male; Muscle, Smooth, Vascular; Norepinephrine; Prazosin; Regional Blood Flow; Serotonin; Vasoconstriction; Yohimbine | 1994 |
5-Hydroxytryptamine 5-HT1D receptors mediating inhibition of cyclic AMP accumulation in Madin-Darby canine kidney (MDCK) cells.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Alprostadil; Animals; Cells, Cultured; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Epithelial Cells; Epithelium; Ketanserin; Kidney Cortex; Methiothepin; Oxadiazoles; Pertussis Toxin; Piperazines; Propranolol; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Sumatriptan; Virulence Factors, Bordetella; Yohimbine | 1995 |
Basal forebrain cholinergic immunolesion by 192IgG-saporin: evidence for a presynaptic location of subpopulations of alpha 2- and beta-adrenergic as well as 5-HT2A receptors on cortical cholinergic terminals.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acetylcholinesterase; Animals; Antibodies, Monoclonal; Autoradiography; Cerebral Cortex; Cholinergic Fibers; Dihydroalprenolol; Immunotoxins; Isotope Labeling; Ketanserin; Male; N-Glycosyl Hydrolases; Prazosin; Presynaptic Terminals; Prosencephalon; Radioligand Assay; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Receptors, Presynaptic; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Ribosome Inactivating Proteins, Type 1; Saporins; Tritium; Yohimbine | 1997 |
Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Benzofurans; Body Temperature; Cerebral Cortex; Dopamine Antagonists; Dose-Response Relationship, Drug; Fenclonine; Fenfluramine; Haloperidol; Hydroxyindoleacetic Acid; Hypothalamus; Hypothermia; Ketanserin; Male; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sertraline; Sulpiride; Yohimbine | 2000 |
Peripheral 5-HT(2A)-receptor-mediated formation of an inhibitor of atrial natriuretic peptide binding involves inflammation.
Topics: Adrenergic alpha-Antagonists; alpha-Methyltyrosine; Animals; Atrial Natriuretic Factor; Catecholamines; Cyclooxygenase Inhibitors; Dexamethasone; Ditiocarb; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Indomethacin; Inflammation; Isatin; Ketanserin; Muscle, Smooth; Prazosin; Propranolol; Protein Binding; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Serotonin, 5-HT2A; Receptors, Angiotensin; Receptors, Serotonin; Reserpine; Ritanserin; Serotonin; Serotonin Receptor Agonists; Tyrosine 3-Monooxygenase; Urination; Vascular Resistance; Yohimbine | 2002 |
Involvement of 5-HT2 receptors in the antinociceptive effect of Uncaria tomentosa.
Topics: Acetic Acid; Analgesics; Animals; Arginine; Atropine; Behavior, Animal; Capsaicin; Cat's Claw; Dose-Response Relationship, Drug; Formaldehyde; Ketanserin; Male; Mice; Motor Activity; Naltrexone; Pain; Pain Measurement; Phytotherapy; Plant Preparations; Prazosin; Receptors, Serotonin, 5-HT2; Reserpine; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Yohimbine | 2005 |
Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Buspirone; Clozapine; Decerebrate State; Dose-Response Relationship, Drug; Drug Interactions; Ergotamine; Heart Rate; Ketanserin; Lisuride; Male; Metergoline; Methiothepin; Methysergide; Phenylephrine; Piperazines; Pizotyline; Prazosin; Pyridines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Serotonin Antagonists; Serotonin Receptor Agonists; Yohimbine | 2006 |
The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.
Topics: Adrenergic alpha-Antagonists; Analgesics; Animals; Biogenic Monoamines; Dose-Response Relationship, Drug; Fenclonine; Hot Temperature; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Ketanserin; Male; Mice; Mice, Inbred ICR; Naloxone; Narcotic Antagonists; Neural Pathways; Norepinephrine; Oxidopamine; Pain Measurement; Physical Stimulation; Reaction Time; Serotonin; Serotonin Agents; Sympatholytics; Thyrotropin; Thyrotropin-Releasing Hormone; Yohimbine | 2007 |
Involvement of Descending Serotonergic and Noradrenergic Systems and their Spinal Receptor Subtypes in the Antinociceptive Effect of Dipyrone.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Neurons; Analgesics; Animals; Dipyrone; Dose-Response Relationship, Drug; Injections, Spinal; Ketanserin; Mice; Ondansetron; Oxidopamine; Pain Measurement; Piperidines; Prazosin; Propranolol; Receptors, Adrenergic, beta; Receptors, Serotonin; Serotonergic Neurons; Spinal Cord; Sulfonamides; Yohimbine | 2015 |
Serotonergic and dopaminergic systems are implicated in antidepressant-like effects of chotosan, a Kampo formula, in mice.
Topics: Animals; Antidepressive Agents; Disease Models, Animal; Dopamine Agents; Drugs, Chinese Herbal; Fenclonine; Imipramine; Ketanserin; Locomotion; Male; Medicine, Kampo; Metergoline; Mice; Piperazines; Pyridines; Serotonin Agents; Sulpiride; Swimming; Yohimbine | 2017 |